# A Study of Single Dose of BL0175 in Postmenopausal Women

> **NCT07366632** · PHASE1 · NOT_YET_RECRUITING · sponsor: **Shanghai Best-Link Bioscience, LLC** · enrollment: 27 (estimated)

## Conditions studied

- Postmenopausal Women

## Interventions

- **DRUG:** BL0175
- **DRUG:** Fulvestrant

## Key facts

- **NCT ID:** NCT07366632
- **Lead sponsor:** Shanghai Best-Link Bioscience, LLC
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-01-26
- **Primary completion:** 2026-05-08
- **Final completion:** 2026-12-21
- **Target enrollment:** 27 (ESTIMATED)
- **Last updated:** 2026-01-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07366632

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07366632, "A Study of Single Dose of BL0175 in Postmenopausal Women". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT07366632. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*